Baricitinib for Moderate and Severe Traumatic Intracerebral Hemorrhage/Contusions
Baricitinib for Moderate and Severe Traumatic Intracerebral Hemorrhage/Contusions
Recruiting · NCT06065046 · Registry updated 2026-04-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Baricitinib for Moderate and Severe Traumatic Intracerebral Hemorrhage/Contusions | Brain Hemorrhage, Traumatic, Brain Injuries, Traumatic, Cerebral Hemorrhage, Traumatic, Craniocerebral Trauma, Intracranial Hemorrhage, Traumatic, Intracranial Hemorrhages, brain disorder, brain injury, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, injury, intracerebral hemorrhage, nervous system disorder, nervous system injury, vascular disorder | Recruiting | Phase 2 | 2026-04-13 | NCT06065046 |
13 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Tandu Hospital, Fourth Military Medical University | Xi'an | China | 1 |